What is he best known for?
The fields of study he is best known for:
Matthew M. Rechler mostly deals with Internal medicine, Endocrinology, Growth factor, Receptor and Somatomedin.
His Stimulation, Insulin resistance, Glucose tolerance test and Granulosa cell study in the realm of Internal medicine connects with subjects such as Ataxia-telangiectasia.
His work in the fields of Endocrinology, such as Ovarian follicle, overlaps with other areas such as Follicular fluid.
Growth factor connects with themes related to Molecular biology in his study.
His Receptor research integrates issues from Insulin receptor and Insulin.
In his study, Fibroblast and Peptide is inextricably linked to Insulin-like growth factor-binding protein, which falls within the broad field of Somatomedin.
His most cited work include:
- Insulin-like growth factor binding proteins. (721 citations)
- Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. (292 citations)
- Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. (277 citations)
What are the main themes of his work throughout his whole career to date?
Matthew M. Rechler mainly investigates Endocrinology, Internal medicine, Molecular biology, Growth factor and Receptor.
He has included themes like Insulin-like growth factor 2 and Insulin-like growth factor in his Endocrinology study.
His Internal medicine research incorporates elements of Binding protein, Sephadex, Antibody and In vitro.
The various areas that he examines in his Molecular biology study include Cell culture, Transfection, Biochemistry, Transcription factor and Messenger RNA.
His specific area of interest is Growth factor, where Matthew M. Rechler studies Insulin-like growth factor-binding protein.
His Receptor research is multidisciplinary, incorporating perspectives in Embryo and Binding site.
He most often published in these fields:
- Endocrinology (51.59%)
- Internal medicine (51.59%)
- Molecular biology (40.13%)
What were the highlights of his more recent work (between 1994-2009)?
- Molecular biology (40.13%)
- Insulin-like growth factor-binding protein (19.11%)
- Growth factor (40.13%)
In recent papers he was focusing on the following fields of study:
Matthew M. Rechler mainly focuses on Molecular biology, Insulin-like growth factor-binding protein, Growth factor, Transfection and Transcription factor.
His Molecular biology research is multidisciplinary, incorporating elements of Cell culture, FOXO1, Protein subunit, Messenger RNA and Transcription.
Research on Biochemistry and Receptor is a part of his Insulin-like growth factor-binding protein study.
His research in Growth factor intersects with topics in Gene, Recombinant DNA, Cell growth, Hepatocyte and DNA synthesis.
The Transcription factor study combines topics in areas such as Protein kinase B and Insulin receptor.
His Endocrinology research focuses on Somatomedin in particular.
Between 1994 and 2009, his most popular works were:
- Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. (143 citations)
- The Coactivator p300 Directly Acetylates the Forkhead Transcription Factor Foxo1 and Stimulates Foxo1-induced Transcription (99 citations)
- Regulatory Actions of Insulin-like Growth Factor-binding Proteins (97 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Molecular biology, Growth factor, Transfection, Insulin-like growth factor and Insulin-like growth factor-binding protein.
His work carried out in the field of Molecular biology brings together such families of science as FOXD3, Forkhead box L2, Forkhead Transcription Factors, FOXO3 and FOXA2.
His study in Growth factor is interdisciplinary in nature, drawing from both Cell culture and Cell.
His Cell culture study incorporates themes from Protein subunit, Messenger RNA and Transcription.
The various areas that Matthew M. Rechler examines in his Insulin-like growth factor study include Growth factor receptor inhibitor, Growth factor receptor, Growth inhibition and Somatomedin.
His Insulin-like growth factor-binding protein research is covered under the topics of Receptor and Biochemistry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
